Insight into Chris Davis (Trades, Portfolio)'s Strategic Moves in Q1 2026
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Insight into Chris Davis (Trades, Portfolio)'s Strategic Moves in Q1 2026
The most significant insight currently obscured by CVS Health's (CVS) headline revenue growth is a high-stakes transition: the company is attempting to use a temporary surge in insurance profitability to outrun the structural margin pressures facing its pharmacy benefit management (PBM) business.
Investors were underwhelmed by the solid earnings posted by The Cigna Group ( NYSE:CI ) recently. Our analysis says...
With an upside potential of 20.18% as of May 3, The Cigna Group (NYSE:CI) is included among the 10 Best Fortune 500 Stocks to Buy According to Analysts. The Cigna Group (NYSE:CI) is a global health company that provides insurance and related products and services. It operates through two segments: Evernorth Health Services and Cigna Healthcare. […]
Shares of health insurance company Cigna (NYSE:CI) fell 2.5% in the afternoon session after the company announced it will exit the Affordable Care Act (ACA) marketplace in 2027, which overshadowed a strong first-quarter earnings report.
Investors in The Cigna Group ( NYSE:CI ) had a good week, as its shares rose 2.6% to close at US$283 following the...
Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q1 CY2026, with sales up 4.7% year on year to $68.52 billion. Its non-GAAP profit of $7.79 per share was 2.4% above analysts’ consensus estimates.
The Cigna Group (NYSE:CI) reported a strong start to 2026 and raised its full-year adjusted earnings outlook following first-quarter results that management said exceeded expectations in key areas, while also announcing additional portfolio changes and providing an update on its leadership transitio
Moby summary of Cigna Corporation's Q1 2026 earnings call
The move follows Aetna’s departure from the ACA market, which has seen significantly declining membership amid rising premium bills.
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The company modestly raised its forecast for 2026 profits amid a shift in its drug pricing and CEO transition.